MedPage Today

Immuno-Oncology Tops Embolization for Intermediate-Grade Liver Cancer

SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended ...
MedPage Today

In Hepatocellular Carcinoma, is TACE Always a Threat?

Transarterial chemoembolization (TACE), a minimally invasive procedure for liver cancer, is an effective treatment strategy for patients with large, asymptomatic, or multifocal hepatocellular ...
ascopubs.org

Surgical resection versus thermal ablation: Comparison of sequential options after successful TACE downstaging therapy for unresectable hepatocellular carcinoma—A long-term ...

Inpatient mortality outcomes of patients with hepatocellular carcinoma with congestive heart failure: A nationwide retrospective cohort study. This is an ASCO Meeting Abstract from the 2024 ASCO ...
ascopubs.org

Plans among American medical oncologists (AMO) for inclusion of trans-arterial chemo-embolization (TACE) as part of first-line therapy in patients with liver only ...

Correlation of pain and depression with tumor extent in patients with resected pancreas cancer. Background: TACE is a widely applied management strategy for patients with HCC. Methods: Using an ...
Healio

TACE plus microwave ablation shows comparable survival, ‘better tumor control’ for HCC

Transcatheter arterial chemoembolization alone and with microwave ablation yielded comparable overall survival rates in patients with recurrent small hepatocellular carcinoma after resection, per ...